Rheumatoid arthritis trials in Belgium
17 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
- Where
- Diepenbeek, Gent
- Age
- 18 years to 75 years
- People
- 21 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07363590 · EU 2025-523412-36-00 - Phase 1Taking peopleStudy Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
- Where
- Antwerp, Edegem, Leuven, Liège
- Age
- 18 years to 65 years
- People
- 48 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07201558 · EU 2025-522273-10-00 - Phase 1/2Taking peopleA Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
- Where
- Leuven, Merksem
- Age
- 18 years to 65 years
- People
- 84 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07412704 · EU 2025-520666-22-00 - Phase 2Taking peopleA Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
- Where
- Brussels, Leuven
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07137598 - Phase 2Taking peopleAn Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
- Where
- Anderlecht, Leuven
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07620392 · EU 2025-523579-47-00 - Phase 1Not yet taking people in BelgiumA Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
- Where
- Leuven
- Age
- 18 years and over
- People
- 60 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07873931 - Phase 2Taking peopleA Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- Where
- Brussels, Ghent, Leuven, Liège
- Age
- 18 years to 75 years
- People
- 220 worldwide
- Run by
- Amgen
See details and how to joinNCT06570798 - Phase 2Taking peopleA Study to Assess the Efficacy and Safety of RO7790121 in Patients with Moderate to Severe Rheumatoid Arthritis who have not Responded to or who Cannot Tolerate TNF and/or JAK Inhibitors
- Where
- Anderlecht, Leuven
- Age
- 18 years and over
- People
- 89 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2025-521034-28-00 · EU 2025-521034-28-00 - Phase 4Taking people3TR-PARTNER-RA
- Where
- Sint-Lambrechts-Woluwe
- Age
- 18 years and over
- People
- 182 worldwide
- Run by
- Queen Mary University Of London
See details and how to join2024-511470-79-00 · EU 2024-511470-79-00 - Phase 1Taking peopleA Study to Evaluate Targeted Therapies for Patients with Rheumatoid Arthritis
- Where
- Gent
- Age
- 18 years and over
- People
- 19 worldwide
- Run by
- AbbVie Deutschland GmbH & Co. KG
See details and how to join2025-523127-21-00 · EU 2025-523127-21-00 - Phase 4Taking peopleThe 3TR Molecular Pathobiology-Driven Precision Therapy in RA (3TR Precis-The-RA) study
- Where
- Sint-Lambrechts-Woluwe
- Age
- 18 years and over
- People
- 197 worldwide
- Run by
- Queen Mary University Of London
See details and how to join2022-502021-18-00 · EU 2022-502021-18-00 - Phase 1Taking peopleA placebo-controlled, single-blind, phase I study in healthy volunteers and patients with Rheumatoid Arthritis with ABO21009
- Where
- Edegem, Liège
- Age
- 18 years and over
- People
- 78 worldwide
- Run by
- Aboleris Holdco
See details and how to join2024-517547-31-00 · EU 2024-517547-31-00 - Phase 4Taking peopleStudy of clinical response, MRI progression, synovitis and changes in gene expression profiles in response to Sarilumab in patients with rheumatoid arthritis not responding to ANTI-TNF therapy
- Where
- Sint-Lambrechts-Woluwe
- Age
- 18 years and over
- People
- 30
- Run by
- Cliniques Universitaires Saint-Luc
See details and how to join2024-514201-61-00 · EU 2024-514201-61-00 - No phaseEnrolling by invitationG7 Dual Mobility With Vivacit-E or Longevity PMCF
- Where
- Leuven
- Age
- 18 years to 80 years
- People
- 358 worldwide
- Run by
- Zimmer Biomet
See details and how to joinNCT05548972 - No phaseTaking peopleMedical Follow-up of New Cases of Polyarthritis in Children and Young Adults
- Where
- Brussels
- Age
- 2 years to 50 years
- People
- 1,000
- Run by
- Université Catholique de Louvain
See details and how to joinNCT07000916 - Phase 4Taking peopleTapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-guided Dose Reduction in Patients With Rheumatoid Arthritis
- Where
- Aalst, Antwerp, Bonheiden, Edegem, Genk, Herentals, Jette, Leuven, Roeselare, Sint-Lambrechts-Woluwe
- Age
- 18 years and over
- People
- 134
- Run by
- Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT06003283 · EU 2023-506638-59-01 - No phaseEnrolling by invitationJuvenile Inflammatory Rheumatism (JIR) Cohorte
- Where
- Brussels, Charleroi, Leuven, Liège
- People
- 15,000 worldwide
- Run by
- Michaël Hofer
See details and how to joinNCT02377245